For example, osteoprotegerin is elevated in the serum of patients with polyvascular atherosclerotic disease [39,40] and, in animal models, inhibits arterial calcification without affecting the development of the number and volume of atherosclerotic lesions [41]. The gene discussed is TNFRSF11B; the disease is calcification.